Sylogist Ltd. (TSE:SYZ - Get Free Report)'s share price rose 0.4% during mid-day trading on Tuesday . The stock traded as high as C$8.60 and last traded at C$8.42. Approximately 3,110 shares changed hands during mid-day trading, a decline of 94% from the average daily volume of 54,717 shares. The stock had previously closed at C$8.39.
Sylogist Stock Performance
The stock has a fifty day moving average price of C$8.43 and a 200-day moving average price of C$9.41. The company has a current ratio of 0.54, a quick ratio of 0.51 and a debt-to-equity ratio of 47.19. The firm has a market capitalization of C$208.08 million, a price-to-earnings ratio of 195.29 and a beta of 0.82.
Sylogist Announces Dividend
The company also recently declared a quarterly dividend, which was paid on Wednesday, March 12th. Shareholders of record on Wednesday, March 12th were given a $0.01 dividend. The ex-dividend date of this dividend was Friday, February 28th. This represents a $0.04 dividend on an annualized basis and a yield of 0.45%. Sylogist's dividend payout ratio (DPR) is presently 88.77%.
About Sylogist
(
Get Free Report)
Sylogist Ltd., a software company, provides mission-critical software-as-a-service solutions in Canada, the United States, and the United Kingdom. The company offers SylogistMission constituent relationship management system, which includes donor management, fundraising, volunteer management, and program delivery; and enterprise resource management, such as accounting and financial management, grant and award management, budget management, payroll and human resources, analytics and reporting, and support and training.
Further Reading
Before you consider Sylogist, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sylogist wasn't on the list.
While Sylogist currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.